240 related articles for article (PubMed ID: 18031829)
1. Inhibition of T cell proliferation by cholera toxin involves the modulation of costimulatory molecules CTLA-4 and CD28.
Vendetti S; Riccomi A; Sacchi A; Sciaraffia E; Gatta L; Pioli C; De Magistris MT
Immunol Lett; 2008 Jan; 115(1):59-69. PubMed ID: 18031829
[TBL] [Abstract][Full Text] [Related]
2. CD40L, CD28, and CTLA-4 expression on CD4+ T cells in kidney graft recipients: a relationship with post-transplantation clinical course.
Kosmaczewska A; Magott-Procelewska M; Frydecka I; Ciszak L; Bocko D; Szteblich A; Kusnierczyk P; Patrzalek D; Szyber P; Klinger M
Transpl Immunol; 2006 Jun; 16(1):32-40. PubMed ID: 16701174
[TBL] [Abstract][Full Text] [Related]
3. Antibodies recognizing CD24 LAP epitope on human T cells enhance CD28 and IL-2 T cell proliferation.
Salamone MC; Rosselot C; Salamone GV; Barboza M; Kado M; Fainboim L
J Leukoc Biol; 2001 Feb; 69(2):215-23. PubMed ID: 11272271
[TBL] [Abstract][Full Text] [Related]
4. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
[TBL] [Abstract][Full Text] [Related]
5. CTLA-4-Mediated inhibition of early events of T cell proliferation.
Brunner MC; Chambers CA; Chan FK; Hanke J; Winoto A; Allison JP
J Immunol; 1999 May; 162(10):5813-20. PubMed ID: 10229815
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
Tenorio EP; Saavedra R
Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
[TBL] [Abstract][Full Text] [Related]
7. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells.
Sugita S; Keino H; Futagami Y; Takase H; Mochizuki M; Stein-Streilein J; Streilein JW
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5376-84. PubMed ID: 17122127
[TBL] [Abstract][Full Text] [Related]
8. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M; Phan TT; Searle PF
Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
[TBL] [Abstract][Full Text] [Related]
9. CTLA-4 expression in T cells of patients with atopic dermatitis.
Choi SY; Sohn MH; Kwon BC; Kim KE
Pediatr Allergy Immunol; 2005 Aug; 16(5):422-7. PubMed ID: 16101935
[TBL] [Abstract][Full Text] [Related]
10. Dietary eicosapentaenoic acid modulates CTLA-4 expression in murine CD4+ T-cells.
Ly LH; Smith R; Switzer KC; Chapkin RS; McMurray DN
Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):29-37. PubMed ID: 16221546
[TBL] [Abstract][Full Text] [Related]
11. Regulation of CD28 expression on CD8+ T cells by CTLA-4.
Berg M; Zavazava N
J Leukoc Biol; 2008 Apr; 83(4):853-63. PubMed ID: 18162511
[TBL] [Abstract][Full Text] [Related]
12. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients.
Takahashi N; Matsumoto K; Saito H; Nanki T; Miyasaka N; Kobata T; Azuma M; Lee SK; Mizutani S; Morio T
J Immunol; 2009 May; 182(9):5515-27. PubMed ID: 19380800
[TBL] [Abstract][Full Text] [Related]
13. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
Biburger M; Weth R; Wels WS
J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
[TBL] [Abstract][Full Text] [Related]
14. Rottlerin inhibits human T cell responses.
Springael C; Thomas S; Rahmouni S; Vandamme A; Goldman M; Willems F; Vosters O
Biochem Pharmacol; 2007 Feb; 73(4):515-25. PubMed ID: 17141738
[TBL] [Abstract][Full Text] [Related]
15. The CD4+CD25 bright regulatory T cells and CTLA-4 expression in peripheral and decidual lymphocytes are down-regulated in human miscarriage.
Jin LP; Chen QY; Zhang T; Guo PF; Li DJ
Clin Immunol; 2009 Dec; 133(3):402-10. PubMed ID: 19766059
[TBL] [Abstract][Full Text] [Related]
16. 4-1BBL costimulation retrieves CD28 expression in activated T cells.
Habib-Agahi M; Jaberipour M; Searle PF
Cell Immunol; 2009; 256(1-2):39-46. PubMed ID: 19217084
[TBL] [Abstract][Full Text] [Related]
17. Surface CD152 (CTLA-4) expression and signaling dictates longevity of CD28null T cells.
Hoff H; Knieke K; Cabail Z; Hirseland H; Vratsanos G; Burmester GR; Jorch G; Nadler SG; Bröker B; Hebel K; Brunner-Weinzierl MC
J Immunol; 2009 May; 182(9):5342-51. PubMed ID: 19380781
[TBL] [Abstract][Full Text] [Related]
18. Expression of CTLA-4 (CD152) in peripheral blood T cells of children with influenza virus infection including encephalopathy in comparison with respiratory syncytial virus infection.
Ayukawa H; Matsubara T; Kaneko M; Hasegawa M; Ichiyama T; Furukawa S
Clin Exp Immunol; 2004 Jul; 137(1):151-5. PubMed ID: 15196256
[TBL] [Abstract][Full Text] [Related]
19. Characterization of CD25-positive T cells during syngeneic pregnancy: production of stimulatory class II MHC molecules.
Kyvelidou C; Chatzi K; Semitekolou M; Papathanassiou X; Vassiliadis S; Athanassakis I
Scand J Immunol; 2009 Dec; 70(6):584-95. PubMed ID: 19906201
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 blockade by a human MAb enhances the capacity of AML-derived DC to induce T-cell responses against AML cells in an autologous culture system.
Zhong RK; Loken M; Lane TA; Ball ED
Cytotherapy; 2006; 8(1):3-12. PubMed ID: 16627340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
